| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 14.047 | 45.980 | 53.821 | 67.514 | 87.415 | 86.592 | 100.058 | 137.866 | 153.287 |
| Total Income - EUR | - | 14.047 | 45.980 | 53.827 | 67.517 | 87.417 | 86.607 | 100.089 | 137.882 | 153.304 |
| Total Expenses - EUR | - | 8.403 | 17.180 | 16.773 | 19.159 | 18.433 | 18.326 | 24.291 | 26.470 | 28.531 |
| Gross Profit/Loss - EUR | - | 5.644 | 28.800 | 37.054 | 48.358 | 68.985 | 68.281 | 75.799 | 111.412 | 124.774 |
| Net Profit/Loss - EUR | - | 5.360 | 28.340 | 36.516 | 47.683 | 68.167 | 67.415 | 74.926 | 110.060 | 120.170 |
| Employees | - | 2 | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dermlife Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 4.618 | 2.736 | 1.074 | 483 | 916 | 1.011 | 798 | 1.032 | 469 |
| Current Assets | - | 3.642 | 26.602 | 36.264 | 48.513 | 68.672 | 68.158 | 75.915 | 111.103 | 126.384 |
| Inventories | - | 363 | 0 | 0 | 0 | 0 | 0 | 149 | 264 | 0 |
| Receivables | - | 2.948 | 3.903 | 4.283 | 5.688 | 8.264 | 5.540 | 52.913 | 82.024 | 84.112 |
| Cash | - | 331 | 22.699 | 31.981 | 42.825 | 60.408 | 62.618 | 22.853 | 28.815 | 42.271 |
| Shareholders Funds | - | 5.405 | 28.384 | 36.559 | 47.725 | 68.208 | 67.456 | 74.967 | 110.101 | 120.219 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.855 | 954 | 780 | 1.271 | 1.380 | 1.713 | 1.808 | 2.039 | 6.798 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermlife Med Srl